Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-013665
Filing Date
2023-05-22
Accepted
2023-05-22 21:19:26
Documents
1
Period of Report
2023-05-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6132
  Complete submission text file 0000899243-23-013665.txt   7563
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Issuer) CIK: 0000730272 (see all company filings)

EIN.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O CODIAK BIOSCIENCES, INC. 500 TECHNOLOGY SQUARE, 9TH FLOOR CAMBRIDGE MA 02139
Business Address
Konstantinov Konstantin (Reporting) CIK: 0001774649 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-14656 | Film No.: 23946350